_id
690f3798ccc777a4e85d17f8
Ticker
BOPCF
Name
BioPharma Credit PLC
Exchange
PINK
Address
65 Gresham Street, London, United Kingdom, EC2V 7NQ
Country
USA
Sector
Industry
Currency
USD
Website
https://www.bpcruk.com
Description
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Last Close
0.00000656092
Volume
180840
Current Price
0.8503
Change
12959972.672734922
Last Updated
2025-11-08T12:29:12.048Z
Image
-
Ipo Date
-
Market Cap
1161350784
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Current Quarter
2024-12-31
Revenue
45312000
Cost Of Revenue
-12240000
Gross Profit
57552000
Operating Expenses
-4939000
Operating Income
50251000
Interest Expense
-
Pretax Income
50340000
Net Income
50340000
Eps
0.0411826176538301
Dividends Per Share
66664000
Shares Outstanding
1222360376
Income Tax Expense
-
EBITDA
-71838000
Cash
5620000
Short Term Investments
-
Receivables
31797000
Inventories
-
Total Current Assets
37417000
Property Plant Equipment
-
Total Assets
1199617000
Payables
946000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
17939000
Equity
1181678000
Depreciation
71838000
Change In Working Capital
6332000
Cash From Operations
64269000
Capital Expenditures
0
Cash From Investing
-1000
Cash From Financing
-95790000
Net Change In Cash
-31524000
PE
13.3774
PB
0.8795738159742331
ROE
4.260043768268513
ROA
4.196339331636681
FCF
64269000
Fcf Percent
1.418365995762712
Piotroski FScore
4
Health Score
76
Deep Value Investing Score
8
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
9.8
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
5.5
Net Net Investing Score
4
Quality Investing Score
7
Value Investing Score
9.5
Quarters > 0 > quarter
2024-12-31
Quarters > 0 > income Statement > revenue
45312000
Quarters > 0 > income Statement > cost Of Revenue
-12240000
Quarters > 0 > income Statement > gross Profit
57552000
Quarters > 0 > income Statement > operating Expenses
-4939000
Quarters > 0 > income Statement > operating Income
50251000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
50340000
Quarters > 0 > income Statement > net Income
50340000
Quarters > 0 > income Statement > eps
0.0411826176538301
Quarters > 0 > income Statement > dividends Per Share
66664000
Quarters > 0 > income Statement > shares Outstanding
1222360376
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-71838000
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
5620000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
31797000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
37417000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
1199617000
Quarters > 0 > balance Sheet > payables
946000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
17939000
Quarters > 0 > balance Sheet > equity
1181678000
Quarters > 0 > cash Flow > net Income
50340000
Quarters > 0 > cash Flow > depreciation
71838000
Quarters > 0 > cash Flow > change In Working Capital
6332000
Quarters > 0 > cash Flow > cash From Operations
64269000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-1000
Quarters > 0 > cash Flow > cash From Financing
-95790000
Quarters > 0 > cash Flow > net Change In Cash
-31524000
Quarters > 0 > ratios > PE
0.0411826176538301
Quarters > 0 > ratios > PB
0.8795738159742331
Quarters > 0 > ratios > ROE
4.260043768268513
Quarters > 0 > ratios > ROA
4.196339331636681
Quarters > 0 > ratios > FCF
64269000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
1.418365995762712
Quarters > 0 > health Score
76
Quarters > 1 > quarter
2024-06-30
Quarters > 1 > income Statement > revenue
79145000
Quarters > 1 > income Statement > cost Of Revenue
12240000
Quarters > 1 > income Statement > gross Profit
79145000
Quarters > 1 > income Statement > operating Expenses
7218000
Quarters > 1 > income Statement > operating Income
71927000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
71838000
Quarters > 1 > income Statement > net Income
71838000
Quarters > 1 > income Statement > eps
0.05765131323388568
Quarters > 1 > income Statement > dividends Per Share
107998000
Quarters > 1 > income Statement > shares Outstanding
1246077426
Quarters > 1 > income Statement > income Tax Expense
35919000
Quarters > 1 > income Statement > EBITDA
71838000
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
37144000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
36881000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
74151000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
1231609000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3535000
Quarters > 1 > balance Sheet > equity
1228074000
Quarters > 1 > cash Flow > net Income
71838000
Quarters > 1 > cash Flow > depreciation
-71838000
Quarters > 1 > cash Flow > change In Working Capital
-16690000
Quarters > 1 > cash Flow > cash From Operations
47643000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
39073000
Quarters > 1 > cash Flow > cash From Financing
-184625000
Quarters > 1 > cash Flow > net Change In Cash
-97909000
Quarters > 1 > ratios > PE
0.05765131323388568
Quarters > 1 > ratios > PB
0.8627653018692685
Quarters > 1 > ratios > ROE
5.849647496812081
Quarters > 1 > ratios > ROA
5.832857668302196
Quarters > 1 > ratios > FCF
47643000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.6019710657653674
Quarters > 1 > health Score
78
Quarters > 2 > quarter
2024-03-31
Quarters > 2 > income Statement > revenue
39572500
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
39572500
Quarters > 2 > income Statement > operating Expenses
3609000
Quarters > 2 > income Statement > operating Income
35963500
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
35919000
Quarters > 2 > income Statement > net Income
35919000
Quarters > 2 > income Statement > eps
0.02882565661694284
Quarters > 2 > income Statement > dividends Per Share
53999000
Quarters > 2 > income Statement > shares Outstanding
1246077426
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
44500
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
37144000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
36881000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
74151000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1231609000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3535000
Quarters > 2 > balance Sheet > equity
1228074000
Quarters > 2 > cash Flow > net Income
35919000
Quarters > 2 > cash Flow > depreciation
-35919000
Quarters > 2 > cash Flow > change In Working Capital
-8345000
Quarters > 2 > cash Flow > cash From Operations
23821500
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-92312500
Quarters > 2 > cash Flow > net Change In Cash
-48954500
Quarters > 2 > ratios > PE
0.02882565661694284
Quarters > 2 > ratios > PB
0.8627653018692685
Quarters > 2 > ratios > ROE
2.9248237484060406
Quarters > 2 > ratios > ROA
2.916428834151098
Quarters > 2 > ratios > FCF
23821500
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.6019710657653674
Quarters > 2 > health Score
72
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
57221000
Quarters > 3 > income Statement > cost Of Revenue
18629000
Quarters > 3 > income Statement > gross Profit
57221000
Quarters > 3 > income Statement > operating Expenses
19693000
Quarters > 3 > income Statement > operating Income
37528000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
37523000
Quarters > 3 > income Statement > net Income
37523000
Quarters > 3 > income Statement > eps
0.02880470787283646
Quarters > 3 > income Statement > dividends Per Share
22797000
Quarters > 3 > income Statement > shares Outstanding
1302669000
Quarters > 3 > income Statement > income Tax Expense
-7000
Quarters > 3 > income Statement > EBITDA
-7000
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
135053000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
20226000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
155370000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
1356732000
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
15871000
Quarters > 3 > balance Sheet > equity
1340861000
Quarters > 3 > cash Flow > net Income
37523000
Quarters > 3 > cash Flow > depreciation
-37530000
Quarters > 3 > cash Flow > change In Working Capital
31126000
Quarters > 3 > cash Flow > cash From Operations
92776000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
1000
Quarters > 3 > cash Flow > cash From Financing
-25594000
Quarters > 3 > cash Flow > net Change In Cash
67176000
Quarters > 3 > ratios > PE
0.02880470787283646
Quarters > 3 > ratios > PB
0.8260807426720592
Quarters > 3 > ratios > ROE
2.7984257876096033
Quarters > 3 > ratios > ROA
2.7656899078078796
Quarters > 3 > ratios > FCF
92776000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
1.6213627863896123
Quarters > 3 > health Score
73
Valuation > metrics > PE
13.3774
Valuation > metrics > PB
0.8795738159742331
Valuation > final Score
100
Valuation > verdict
6.0% Undervalued
Profitability > metrics > ROE
4.260043768268513
Profitability > metrics > ROA
134.53777694630782
Profitability > metrics > Net Margin
1.1109639830508475
Profitability > final Score
69
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.015180954540915545
Risk > metrics > Interest Coverage
0.41129335886984564
Risk > final Score
62
Risk > verdict
High
Liquidity > metrics > Current Ratio
39.55285412262157
Liquidity > metrics > Quick Ratio
39.55285412262157
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
72
Prev Profitabilities > 1
66
Prev Profitabilities > 2
66
Prev Risks > 0
80
Prev Risks > 1
64
Prev Risks > 2
64
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T21:30:56.972Z
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2024-12-31)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of BioPharma Credit PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-12-31)
(Last Updated 2024-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
(Last Updated 2024-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.